These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 31599678)
21. Hurrah for empirical bioethics (where hermeneutically clarified) or how perception of facts 'depends' on values. Schultz DS Am J Bioeth; 2009; 9(6-7):95-9. PubMed ID: 19998136 [No Abstract] [Full Text] [Related]
22. [Conclusions. The precautionary principle: its advantages and risks]. Tubiana M Bull Acad Natl Med; 2000; 184(5):969-93. PubMed ID: 11077719 [TBL] [Abstract][Full Text] [Related]
23. [Bioethics is dead. Long live medical ethics!]. Barrio Maestre JM Cuad Bioet; 2015; 26(86):25-49. PubMed ID: 26030013 [TBL] [Abstract][Full Text] [Related]
24. Short-circuit to be avoided by bioethics committees. Nature; 1997 May; 387(6631):321. PubMed ID: 9163403 [No Abstract] [Full Text] [Related]
25. Are all rational moralities equivalent? Gunson D Camb Q Healthc Ethics; 2011 Apr; 20(2):238-47. PubMed ID: 21435298 [No Abstract] [Full Text] [Related]
26. Will CRISPR Germline Engineering Close the Door to an Open Future? Mintz RL; Loike JD; Fischbach RL Sci Eng Ethics; 2019 Oct; 25(5):1409-1423. PubMed ID: 30357560 [TBL] [Abstract][Full Text] [Related]
27. Betwixt and between human stem cell guidelines and legislation. Baylis F Health Law Rev; 2002; 11(1):44-50. PubMed ID: 15739317 [No Abstract] [Full Text] [Related]
30. Bioethics in a low key: a report from Germany. Leist A Bioethics; 1993 Apr; 7(2-3):271-9. PubMed ID: 11651541 [TBL] [Abstract][Full Text] [Related]
31. Regulation as facilitation: negotiating the genetic revolution. Black J Mod Law Rev; 1998 Sep; 61(5):621-60. PubMed ID: 14518446 [No Abstract] [Full Text] [Related]
33. Tying Prometheus down: the international law of human genetic manipulation. Marks SP Chic J Int Law; 2002; 3(1):115-36. PubMed ID: 15709303 [No Abstract] [Full Text] [Related]
34. Politics and bioethical commissions: "muddling through" and the "slippery slope". Mendeloff J J Health Polit Policy Law; 1985; 10(1):81-92. PubMed ID: 4020077 [TBL] [Abstract][Full Text] [Related]
35. Ethical, Legal and Social Implications of Emerging Technology (ELSIET) Symposium. Kendal E J Bioeth Inq; 2022 Sep; 19(3):363-370. PubMed ID: 35749026 [No Abstract] [Full Text] [Related]
36. Ethical issues of CRISPR technology and gene editing through the lens of solidarity. Mulvihill JJ; Capps B; Joly Y; Lysaght T; Zwart HAE; Chadwick R; Br Med Bull; 2017 Jun; 122(1):17-29. PubMed ID: 28334154 [TBL] [Abstract][Full Text] [Related]
38. Current ethical issues in synthetic biology: where should we go from here? Newson AJ Account Res; 2011 May; 18(3):181-93. PubMed ID: 21574073 [TBL] [Abstract][Full Text] [Related]
39. Human Germline CRISPR-Cas Modification: Toward a Regulatory Framework. Evitt NH; Mascharak S; Altman RB Am J Bioeth; 2015; 15(12):25-9. PubMed ID: 26632357 [TBL] [Abstract][Full Text] [Related]
40. WHO'S IN CHARGE? THE RELATIONSHIP BETWEEN MEDICAL LAW, MEDICAL ETHICS, AND MEDICAL MORALITY? Foster C; Miola J Med Law Rev; 2015; 23(4):505-30. PubMed ID: 25752596 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]